RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Frida Kleiman to Humans

This is a "connection" page, showing publications Frida Kleiman has written about Humans.
Connection Strength

0.382
  1. Murphy MR, Ramadei A, Doymaz A, Varriano S, Natelson DM, Yu A, Aktas S, Mazzeo M, Mazzeo M, Zakusilo G, Kleiman FE. Long non-coding RNA generated from CDKN1A gene by alternative polyadenylation regulates p21 expression during DNA damage response. Nucleic Acids Res. 2023 Nov 27; 51(21):11911-11926.
    View in: PubMed
    Score: 0.046
  2. Alonso ADC, El Idrissi A, Candia R, Morozova V, Kleiman FE. Tau: More than a microtubule-binding protein in neurons. Cytoskeleton (Hoboken). 2024 Jan; 81(1):71-77.
    View in: PubMed
    Score: 0.046
  3. Murphy MR, Kleiman FE. Connections between 3' end processing and DNA damage response: Ten years later. Wiley Interdiscip Rev RNA. 2020 03; 11(2):e1571.
    View in: PubMed
    Score: 0.035
  4. Fonseca D, Baquero J, Murphy MR, Aruggoda G, Varriano S, Sapienza C, Mashadova O, Rahman S, Kleiman FE. mRNA Processing Factor CstF-50 and Ubiquitin Escort Factor p97 Are BRCA1/BARD1 Cofactors Involved in Chromatin Remodeling during the DNA Damage Response. Mol Cell Biol. 2018 02 15; 38(4).
    View in: PubMed
    Score: 0.031
  5. Zhang X, Devany E, Murphy MR, Glazman G, Persaud M, Kleiman FE. PARN deadenylase is involved in miRNA-dependent degradation of TP53 mRNA in mammalian cells. Nucleic Acids Res. 2015 Dec 15; 43(22):10925-38.
    View in: PubMed
    Score: 0.026
  6. Devany E, Zhang X, Park JY, Tian B, Kleiman FE. Positive and negative feedback loops in the p53 and mRNA 3' processing pathways. Proc Natl Acad Sci U S A. 2013 Feb 26; 110(9):3351-6.
    View in: PubMed
    Score: 0.022
  7. Goss DJ, Kleiman FE. Poly(A) binding proteins: are they all created equal? Wiley Interdiscip Rev RNA. 2013 Mar-Apr; 4(2):167-79.
    View in: PubMed
    Score: 0.022
  8. Nazeer FI, Devany E, Mohammed S, Fonseca D, Akukwe B, Taveras C, Kleiman FE. p53 inhibits mRNA 3' processing through its interaction with the CstF/BARD1 complex. Oncogene. 2011 Jul 07; 30(27):3073-83.
    View in: PubMed
    Score: 0.019
  9. Cevher MA, Kleiman FE. Connections between 3'-end processing and DNA damage response. Wiley Interdiscip Rev RNA. 2010 Jul-Aug; 1(1):193-9.
    View in: PubMed
    Score: 0.018
  10. Cevher MA, Zhang X, Fernandez S, Kim S, Baquero J, Nilsson P, Lee S, Virtanen A, Kleiman FE. Nuclear deadenylation/polyadenylation factors regulate 3' processing in response to DNA damage. EMBO J. 2010 May 19; 29(10):1674-87.
    View in: PubMed
    Score: 0.018
  11. Mirkin N, Fonseca D, Mohammed S, Cevher MA, Manley JL, Kleiman FE. The 3' processing factor CstF functions in the DNA repair response. Nucleic Acids Res. 2008 Apr; 36(6):1792-804.
    View in: PubMed
    Score: 0.015
  12. Kleiman FE, Wu-Baer F, Fonseca D, Kaneko S, Baer R, Manley JL. BRCA1/BARD1 inhibition of mRNA 3' processing involves targeted degradation of RNA polymerase II. Genes Dev. 2005 May 15; 19(10):1227-37.
    View in: PubMed
    Score: 0.013
  13. Ghosh J, Schultz BM, Chan J, Wultsch C, Singh R, Shureiqi I, Chow S, Doymaz A, Varriano S, Driscoll M, Muse J, Kleiman FE, Krampis K, Issa JJ, Sapienza C. Epigenome-Wide Study Identifies Epigenetic Outliers in Normal Mucosa of Patients with Colorectal Cancer. Cancer Prev Res (Phila). 2022 11 01; 15(11):755-766.
    View in: PubMed
    Score: 0.011
  14. Kleiman FE, Manley JL. The BARD1-CstF-50 interaction links mRNA 3' end formation to DNA damage and tumor suppression. Cell. 2001 Mar 09; 104(5):743-53.
    View in: PubMed
    Score: 0.010
  15. Kleiman FE, Manley JL. Functional interaction of BRCA1-associated BARD1 with polyadenylation factor CstF-50. Science. 1999 Sep 03; 285(5433):1576-9.
    View in: PubMed
    Score: 0.009
  16. Kleiman FE, Ram?rez AO, Dodelson de Kremer R, Gravel RA, Argara?a CE. A frequent TG deletion near the polyadenylation signal of the human HEXB gene: occurrence of an irregular DNA structure and conserved nucleotide sequence motif in the 3' untranslated region. Hum Mutat. 1998; 12(5):320-9.
    View in: PubMed
    Score: 0.008
  17. Zhang X, Xiao S, Rameau RD, Devany E, Nadeem Z, Caglar E, Ng K, Kleiman FE, Saxena A. Nucleolin phosphorylation regulates PARN deadenylase activity during cellular stress response. RNA Biol. 2018 02 01; 15(2):251-260.
    View in: PubMed
    Score: 0.008
  18. Kleiman FE, de Kremer RD, de Ramirez AO, Gravel RA, Argara?a CE. Sandhoff disease in Argentina: high frequency of a splice site mutation in the HEXB gene and correlation between enzyme and DNA-based tests for heterozygote detection. Hum Genet. 1994 Sep; 94(3):279-82.
    View in: PubMed
    Score: 0.006
  19. Zhang X, Kleiman FE, Devany E. Deadenylation and its regulation in eukaryotic cells. Methods Mol Biol. 2014; 1125:289-96.
    View in: PubMed
    Score: 0.006
  20. Edwards RA, Lee MS, Tsutakawa SE, Williams RS, Nazeer I, Kleiman FE, Tainer JA, Glover JN. The BARD1 C-terminal domain structure and interactions with polyadenylation factor CstF-50. Biochemistry. 2008 Nov 04; 47(44):11446-56.
    View in: PubMed
    Score: 0.004
  21. Kim HS, Li H, Cevher M, Parmelee A, Fonseca D, Kleiman FE, Lee SB. DNA damage-induced BARD1 phosphorylation is critical for the inhibition of messenger RNA processing by BRCA1/BARD1 complex. Cancer Res. 2006 May 01; 66(9):4561-5.
    View in: PubMed
    Score: 0.003
  22. Shin C, Kleiman FE, Manley JL. Multiple properties of the splicing repressor SRp38 distinguish it from typical SR proteins. Mol Cell Biol. 2005 Sep; 25(18):8334-43.
    View in: PubMed
    Score: 0.003
  23. Chen A, Kleiman FE, Manley JL, Ouchi T, Pan ZQ. Autoubiquitination of the BRCA1*BARD1 RING ubiquitin ligase. J Biol Chem. 2002 Jun 14; 277(24):22085-92.
    View in: PubMed
    Score: 0.003
  24. KLEIMAN F. Obstetric anesthesia; trichlorethylene. Sem Med. 1949 Feb 17; 56(7):207-14.
    View in: PubMed
    Score: 0.000
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support